Search
mRNA-1283
go.drugbank.com/drugs/DB22668ApprovedInvestigationalmRNA-1283 is a nucleoside-modified messenger RNA (mRNA) encoding the N-terminal domain (NTD) and receptor-binding domain (RBD) of the spike glycoprotein of the SARS-CoV-2 Omicron variant lineage JN.1. … spike protein, allowing for a more targeted immune response and the use of a significantly smaller amount of mRNA per dose.
Berahyaluronidase alfa
go.drugbank.com/drugs/DB22790ApprovedInvestigationalIt is used in a fixed-dose combination with [pembrolizumab] for subcutaneous injection. … Berahyaluronidase alfa is a recombinant variant of human hyaluronidase designed to enhance dispersion and permeation of subcutaneously co-administered drugs.
Procizumab
go.drugbank.com/drugs/DB23041InvestigationalProcizumab is under investigation in clinical trial NCT06331884 (Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)).
BNT162B2 Omicron (LP.8.1)
go.drugbank.com/drugs/DB23337Approved[L53723] It encodes the spike protein from the Omicron LP.8.1 subvariant of SARS-CoV-2.[L53723] The 2025-2026 formulation of Pfizer-BioNTech's Comirnaty was approved by the US FDA in August 2025.
Tetramethylpyrazine nitrone
go.drugbank.com/drugs/DB23609InvestigationalSynonyms: (Z)-N-TERT-BUTYL-1-(3,5,6-TRIMETHYLPYRAZIN-2-YL)METHANIMINE OXIDE, N-TERT-BUTYL-1-(3,5,6-TRIMETHYLPYRAZIN-2-YL)METHANIMINE OXIDECategories: Heterocyclic Compounds, 1-RingMesenchymal stem cell-derived exosomes
go.drugbank.com/drugs/DB24445InvestigationalMesenchymal Stem Cell-Derived Exosomes is a biologic drug.
CTA30X UCAR-T
go.drugbank.com/drugs/DB24819InvestigationalCTA30X UCAR-T is a biologic drug. CTA30X UCAR-T is under investigation in clinical trial NCT05015972 (UCAR-T for CD19+ Refractory/Relapsed B Hematologic Malignancies).
Synonyms: CTA30X UCAR-TVH3739937
go.drugbank.com/drugs/DB25287InvestigationalVH3739937 is a small molecule drug. … VH3739937 is under investigation in clinical trial NCT06533280 (VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect
NBQ72S
go.drugbank.com/drugs/DB26052InvestigationalNBQ72S is a small molecule drug. NBQ72S is under investigation in clinical trial NCT06810804 (A Phase IIa Study to Evaluate NBQ72S).